Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of CD160, an Activating NK Cell Receptor, in Melanoma: a Potential Therapeutic Target?	Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, primitive neuroectodermal tumor, skin disorder, skin neoplasm	Not yet recruiting	Not stated	2020-07-20		NCT04477876

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Assistance Publique - Hôpitaux de Paris	985

0 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
No products are listed yet.

Clinical trials